Boston Children's Hospital and Harvard Medical School provided preclinical data for a therapy related to ODD.
1 report, 1 independent
Updated Aug 5
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Boston Children's Hospital and Harvard Medical School provided preclinical data for a therapy related to ODD.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
Related events
- A company is conducting clinical trials and seeking drug approval for the U.S. market under the FDA.
- FDA granted Orphan Drug Designation to BRC's drug.
- The FDA requested additional clinical data from Unicycive Therapeutics.
- FDA approved a medical device from Abbott and supported a PARADIGM study based on data from the Cleveland Clinic.
- FDA approval expands patient access to therapies for ACCORD.